Mar 27, 2025 / 05:00PM GMT
Lucie Larguier - Transgene SA - Chief Financial Officer, Member of the Management Committee
Hello everyone. So I'm Lucy, Chief Finance Officer at Transin. I have the pleasure to introduce you today to Doctor Alexander River, our Chairman in.
We will review our progress of over 2024, which was a great year you'll see and answer any questions you may have.
Before I turn the call over to Alessandro, I'd like to remind everyone that today's discussion contains forward-looking statements. Which are subject to a number of risks and uncertainties. If you are listening to this webcast via the internet, you will not be able to ask questions. And if you wish to do so and ask questions, you can join us via the conference call numbers that are available in the press release issued today, or you can also directly send me an email or to investor relations at trans.
And we'll be happy to read your question and answer it. With this, I now turn the call over to Alexandro.
Alessandro Riva - Transgene SA - Chairman of the Board, Chief Executive Officer, Member of the
Full Year 2024 Transgene SA Earnings Call Transcript
Mar 27, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers